| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917912 | Radiotherapy and Oncology | 2015 | 7 Pages |
Abstract
Our data indicate that IDH1R132H mutation causes both a less aggressive biological behavior and direct radiosensitization of human malignant glioma cells. Targeting IDH1 appears to be an attractive approach in combination with radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jacqueline Kessler, Antje Güttler, Henri Wichmann, Swetlana Rot, Matthias Kappler, Matthias Bache, Dirk Vordermark,
